Arteriovenous hemangioma/malformation
MONDO:0001256A benign vascular lesion characterized by the presence of a complex network of communicating arterial and venous vascular structures.
Also known as: arteriovenous angioma, arteriovenous hemangioma, arteriovenous hemangioma/malformation, racemose aneurysm (morphologic abnormality), racemose hemangioma (morphologic abnormality), arteriovenous malformation, cirsoid aneurysm
1485 clinical trials for this condition and its sub-types, 34 tagged with Arteriovenous hemangioma/malformation itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Arteriovenous hemangioma/malformation
-
Arteriovenous malformations of the brain 32 trials
-
Dural sinus malformation 5 trials
-
Vein of Galen aneurysm 2 trials
-
Cobb syndrome 0 trials
-
Foix-Alajouanine syndrome 0 trials
-
3 sub-types
-
Facial arteriovenous malformation 0 trials
3 sub-types
- Frontonasal arteriovenous malformation 0 trials
- Mandibular arteriovenous malformation 0 trials
- Maxillary arteriovenous malformation 0 trials
-
Brain AVM drug trial pulled before it began
Disease control CancelledThis pilot study aimed to see if the oral drug trametinib could improve the structure of brain arteriovenous malformations (AVMs) in adults before their scheduled surgery. The goal was to shrink the AVM or reduce risky features. However, the trial was withdrawn before enrolling a…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
HHT drug trial pulled before it even started
Disease control CancelledThis was a planned early-stage study of a new drug called TER-1754 for people with hereditary hemorrhagic telangiectasia (HHT), a condition that causes frequent nosebleeds and abnormal blood vessels. The trial aimed to test safety and find the right dose, but it was withdrawn bef…
Phase 1 • Sponsor: Terremoto Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug aims to stop nosebleeds in rare genetic disorder
Disease control OngoingThis study tests a new drug called VAD044 in 75 adults with hereditary hemorrhagic telangiectasia (HHT), a condition that causes frequent nosebleeds and anemia. The first part compares two doses of VAD044 against a placebo to see if it safely reduces the number, length, and sever…
Phase 1/2 • Sponsor: Vaderis Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New laser imaging could help surgeons prevent strokes during brain surgery
Diagnosis PausedThis study tests a laser-based imaging method that shows blood flow in the brain in real time during surgery. It involves 20 adults having brain surgery for conditions like aneurysms. The goal is to see if this technique can give surgeons continuous feedback, unlike the current d…
Sponsor: Andrew Dunn • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New coil survey aims to improve blood vessel treatments
Knowledge-focused By invitation onlyThis study surveys doctors who use Concerto Versa detachable coils to treat various blood vessel conditions like aneurysms and varicose veins. About 30 patients will be included, and doctors report how well the coils work and any problems within 72 hours. The goal is to collect e…
Sponsor: Medtronic Endovascular • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
New registry to monitor safety of LOBO device in bleeding emergencies
Knowledge-focused By invitation onlyThis registry will follow 500 adults who receive the LOBO Vascular Occlusion System, a device used to block blood vessels in cases of arterial bleeding or other conditions. The goal is to see how safe and effective the device is in everyday medical practice. Participants are enro…
Sponsor: Okami Medical, Inc. • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
New registry aims to unlock secrets of rare bleeding disorder
Knowledge-focused OngoingThis study is creating a registry of people with Hereditary Hemorrhagic Telangiectasia (HHT), a rare condition that causes abnormal blood vessels and frequent nosebleeds. Researchers will collect health information from about 1,000 adults over many years to see how the disease ch…
Sponsor: Unity Health Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New needle technique for dialysis access tested against surgery in small pilot
Knowledge-focused OngoingThis study compares a new, less invasive needle-based method (endo-AVF) with traditional surgery for creating arteriovenous fistulas (AVFs) needed for dialysis. About 21 adults will be randomly assigned to one of the two techniques to see if a larger trial is feasible. The goal i…
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC